Perception of teratogenic risk of common medicines

References 

1. McBride WG. Thalidomide and congenital abnormalities. Lancet. 1961;2:1358
   • MEDLINE
2. Lenz W. Thalidomide and congenital abnormalities. Lancet. 1962;1:45
   • MEDLINE
3. De Jon-van den Berg LTW, Van den Berg PB, Haaijer-ruskamp FM, Dukes MNG, Wesseling H. Investigating drug use in pregnancy. Methodological problems and perspectives. Pharmaceutisch Weekblad Sci. Ed. 1991;13(1):32–38
4. Friedman JM, Polifka JE. Teratogenic effects of drugs. A resource for clinicians (TERIS). Baltimore: Johns Hopkins University Press, 1994.
5. Martı́nez-Frias ML. Medicamentos y Teratogenia. Revisión Bibliográfica y situación en España. Madrid: Ministerio de Sanidad y Consumo, 1989.
6. Koren G, Bologa M, Long D, Feldman Y, Shear N. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am. J. Obstet. Gynecol. 1989;160:1190–1204
   • Abstract
   • Full-Text PDF (1743 KB)
7. Koren G, Gladstone D, Robeson C, Robieux I. The perception of teratogenic risk of cocaine. Teratology. 1992;46:567–571
   • MEDLINE
   • CrossRef
8. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. A reference guide to fetal and neonatal risk. Baltimore: Williams & Wilkins, 1990.
9. Garcı́a M, Fernandez-Quintana E, Sanz E, Boada J. Pharmacovigillance and therapeutic information: a part of the health care delivery. In: Proceedings of the VI World Conference on Clinical Pharmacology and Therapeutics, 1996; Buenos Aires. Acta Physiologica Pharmacologica et Therapeutica Latinoamericana (Book of abstracts) 253:122–409.
10. Stichting Health Base. Kinderwens, Zwangerschap en Verantwoord Geneesmiddelengebruik. El Haarlem, 1992.
11. Sanz E, Fernández-Quintana E, Garcı́a M, Boada J. Medicamentos que pueden usarse antes y durante la gestación. Serie Asistencia Sanitaria. Islas Canarias: Servicio Canario de Salud, 1985 (www.fitec.ull.es).